Figure 3: A-J. Horizontal Optical Coherence Tomography (Cirrus OCT) and retinal map at each follow-up between March 2009 and October 2009. A. 3-25-09: Initial presentation. Visual acuity = 20/50, intravitreal ranibizumab (IVR) #1. B. 4-22-09. Visual acuity = 20/30, observation. C. 6-03-09. Visual acuity = 20/40, IVR #2. D. 7-29-09. Visual acuity = 20/25, IVR #3. E. 8-26- 09. Visual acuity = 20/20, IVR #4. F. 10-07-09. Visual acuity = 20/20, IVR #5.